Cargando…
Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes
The syndromes caused by frontotemporal lobar degeneration have highly heterogeneous and overlapping clinical features. There has been great progress in the refinement of clinical diagnostic criteria in the past decade, but we propose that a better understanding of aetiology, pathophysiology and symp...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241953/ https://www.ncbi.nlm.nih.gov/pubmed/32438414 http://dx.doi.org/10.1093/brain/awaa097 |
_version_ | 1783537149074735104 |
---|---|
author | Murley, Alexander G Coyle-Gilchrist, Ian Rouse, Matthew A Jones, P Simon Li, Win Wiggins, Julie Lansdall, Claire Rodríguez, Patricia Vázquez Wilcox, Alicia Tsvetanov, Kamen A Patterson, Karalyn Lambon Ralph, Matthew A Rowe, James B |
author_facet | Murley, Alexander G Coyle-Gilchrist, Ian Rouse, Matthew A Jones, P Simon Li, Win Wiggins, Julie Lansdall, Claire Rodríguez, Patricia Vázquez Wilcox, Alicia Tsvetanov, Kamen A Patterson, Karalyn Lambon Ralph, Matthew A Rowe, James B |
author_sort | Murley, Alexander G |
collection | PubMed |
description | The syndromes caused by frontotemporal lobar degeneration have highly heterogeneous and overlapping clinical features. There has been great progress in the refinement of clinical diagnostic criteria in the past decade, but we propose that a better understanding of aetiology, pathophysiology and symptomatic treatments can arise from a transdiagnostic approach to clinical phenotype and brain morphometry. In a cross-sectional epidemiological study, we examined 310 patients with a syndrome likely to be caused by frontotemporal lobar degeneration, including behavioural variant frontotemporal dementia, non-fluent, and semantic variants of primary progressive aphasia (PPA), progressive supranuclear palsy and corticobasal syndrome. We included patients with logopenic PPA and those who met criteria for PPA but not a specific subtype. To date, 49 patients have a neuropathological diagnosis. A principal component analysis identified symptom dimensions that broadly recapitulated the core features of the main clinical syndromes. However, the subject-specific scores on these dimensions showed considerable overlap across the diagnostic groups. Sixty-two per cent of participants had phenotypic features that met the diagnostic criteria for more than one syndrome. Behavioural disturbance was prevalent in all groups. Forty-four per cent of patients with corticobasal syndrome had progressive supranuclear palsy-like features and 30% of patients with progressive supranuclear palsy had corticobasal syndrome-like features. Many patients with progressive supranuclear palsy and corticobasal syndrome had language impairments consistent with non-fluent variant PPA while patients with behavioural variant frontotemporal dementia often had semantic impairments. Using multivariate source-based morphometry on a subset of patients (n = 133), we identified patterns of covarying brain atrophy that were represented across the diagnostic groups. Canonical correlation analysis of clinical and imaging components found three key brain-behaviour relationships, with a continuous spectrum across the cohort rather than discrete diagnostic entities. In the 46 patients with follow-up (mean 3.6 years) syndromic overlap increased with time. Together, these results show that syndromes associated with frontotemporal lobar degeneration do not form discrete mutually exclusive categories from their clinical features or structural brain changes, but instead exist in a multidimensional spectrum. Patients often manifest diagnostic features of multiple disorders while deficits in behaviour, movement and language domains are not confined to specific diagnostic groups. It is important to recognize individual differences in clinical phenotype, both for clinical management and to understand pathogenic mechanisms. We suggest that a transdiagnostic approach to the spectrum of frontotemporal lobar degeneration syndromes provides a useful framework with which to understand disease aetiology, progression, and heterogeneity and to target future treatments to a higher proportion of patients. |
format | Online Article Text |
id | pubmed-7241953 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-72419532020-05-26 Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes Murley, Alexander G Coyle-Gilchrist, Ian Rouse, Matthew A Jones, P Simon Li, Win Wiggins, Julie Lansdall, Claire Rodríguez, Patricia Vázquez Wilcox, Alicia Tsvetanov, Kamen A Patterson, Karalyn Lambon Ralph, Matthew A Rowe, James B Brain Original Articles The syndromes caused by frontotemporal lobar degeneration have highly heterogeneous and overlapping clinical features. There has been great progress in the refinement of clinical diagnostic criteria in the past decade, but we propose that a better understanding of aetiology, pathophysiology and symptomatic treatments can arise from a transdiagnostic approach to clinical phenotype and brain morphometry. In a cross-sectional epidemiological study, we examined 310 patients with a syndrome likely to be caused by frontotemporal lobar degeneration, including behavioural variant frontotemporal dementia, non-fluent, and semantic variants of primary progressive aphasia (PPA), progressive supranuclear palsy and corticobasal syndrome. We included patients with logopenic PPA and those who met criteria for PPA but not a specific subtype. To date, 49 patients have a neuropathological diagnosis. A principal component analysis identified symptom dimensions that broadly recapitulated the core features of the main clinical syndromes. However, the subject-specific scores on these dimensions showed considerable overlap across the diagnostic groups. Sixty-two per cent of participants had phenotypic features that met the diagnostic criteria for more than one syndrome. Behavioural disturbance was prevalent in all groups. Forty-four per cent of patients with corticobasal syndrome had progressive supranuclear palsy-like features and 30% of patients with progressive supranuclear palsy had corticobasal syndrome-like features. Many patients with progressive supranuclear palsy and corticobasal syndrome had language impairments consistent with non-fluent variant PPA while patients with behavioural variant frontotemporal dementia often had semantic impairments. Using multivariate source-based morphometry on a subset of patients (n = 133), we identified patterns of covarying brain atrophy that were represented across the diagnostic groups. Canonical correlation analysis of clinical and imaging components found three key brain-behaviour relationships, with a continuous spectrum across the cohort rather than discrete diagnostic entities. In the 46 patients with follow-up (mean 3.6 years) syndromic overlap increased with time. Together, these results show that syndromes associated with frontotemporal lobar degeneration do not form discrete mutually exclusive categories from their clinical features or structural brain changes, but instead exist in a multidimensional spectrum. Patients often manifest diagnostic features of multiple disorders while deficits in behaviour, movement and language domains are not confined to specific diagnostic groups. It is important to recognize individual differences in clinical phenotype, both for clinical management and to understand pathogenic mechanisms. We suggest that a transdiagnostic approach to the spectrum of frontotemporal lobar degeneration syndromes provides a useful framework with which to understand disease aetiology, progression, and heterogeneity and to target future treatments to a higher proportion of patients. Oxford University Press 2020-05 /pmc/articles/PMC7241953/ /pubmed/32438414 http://dx.doi.org/10.1093/brain/awaa097 Text en © The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Murley, Alexander G Coyle-Gilchrist, Ian Rouse, Matthew A Jones, P Simon Li, Win Wiggins, Julie Lansdall, Claire Rodríguez, Patricia Vázquez Wilcox, Alicia Tsvetanov, Kamen A Patterson, Karalyn Lambon Ralph, Matthew A Rowe, James B Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes |
title | Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes |
title_full | Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes |
title_fullStr | Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes |
title_full_unstemmed | Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes |
title_short | Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes |
title_sort | redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241953/ https://www.ncbi.nlm.nih.gov/pubmed/32438414 http://dx.doi.org/10.1093/brain/awaa097 |
work_keys_str_mv | AT murleyalexanderg redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes AT coylegilchristian redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes AT rousematthewa redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes AT jonespsimon redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes AT liwin redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes AT wigginsjulie redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes AT lansdallclaire redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes AT rodriguezpatriciavazquez redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes AT wilcoxalicia redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes AT tsvetanovkamena redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes AT pattersonkaralyn redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes AT lambonralphmatthewa redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes AT rowejamesb redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes |